EUVIMEDEUVIMED entdecken
Open Access

Subendothelial Matrix Stiffening by Lysyl Oxidase Enhances RAGE-Mediated Retinal Endothelial Activation in Diabetes

Sathishkumar Chandrakumar iD, Irene Santiago Tierno, Mahesh Agarwal, Nikolaos Matisioudis, Timothy S Kern, Kaustabh Ghosh iD

Diabetes · 2023

DOI: 10.2337/db22-0761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Sathishkumar Chandrakumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California, Riverside, CA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial cell (EC) activation is a crucial determinant of retinal vascular inflammation associated with diabetic retinopathy (DR), a major microvascular complication of diabetes. We previously showed that, similar to abnormal biochemical factors, aberrant mechanical cues in the form of lysyl oxidase (LOX)-dependent subendothelial matrix stiffening also contribute significantly to retinal EC activation in diabetes. Yet, how LOX is itself regulated and precisely how it mechanically controls retinal EC activation in diabetes is poorly understood. Here, we show that high-glucose–induced LOX upregulation in human retinal ECs (HRECs) is mediated by proinflammatory receptor for advanced glycation end products (RAGE). HRECs treated with methylglyoxal (MGO), an active precursor to the advanced glycation end product (AGE) MG-H1, exhibited LOX upregulation that was blocked by a RAGE inhibitor, thus confirming the ability of RAGE to promote LOX expression. Crucially, as a downstream effector of RAGE, LOX was found to mediate both the proinflammatory and matrix remodeling effects of AGE/RAGE, primarily through its ability to crosslink or stiffen matrix. Finally, using decellularized HREC-derived matrices and a mouse model of diabetes, we demonstrate that LOX-dependent matrix stiffening feeds back to enhance RAGE, thereby achieving its autoregulation and proinflammatory effects. Collectively, these findings provide fresh mechanistic insights into the regulation and proinflammatory role of LOX-dependent mechanical cues in diabetes while simultaneously implicating LOX as an alternative (downstream) target to block AGE/RAGE signaling in DR. Article Highlights We investigated the regulation and proinflammatory role of retinal endothelial lysyl oxidase (LOX) in diabetes. Findings reveal that LOX is upregulated by advanced glycation end products (AGE) and receptor for AGE (RAGE) and mediates AGE/RAGE-induced retinal endothelial cell activation and subendothelial matrix remodeling. We also show that LOX-dependent subendothelial matrix stiffening feeds back to enhance retinal endothelial RAGE. These findings implicate LOX as a key proinflammatory factor and an alternative (downstream) target to block AGE/RAGE signaling in diabetic retinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes MellitusMiceAnimalsHumansReceptor for Advanced Glycation End ProductsProtein-Lysine 6-OxidaseRetinaEndotheliumGlycation End Products, Advanced

Substanzen

Receptor for Advanced Glycation End ProductsProtein-Lysine 6-OxidaseGlycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Bioengineering, University of California, Riverside, CA.
  • Department of Ophthalmology, University of California, Los Angeles, CA.
  • Doheny Eye Institute, Pasadena, CA.
  • Molecular, Cellular, and Integrated Physiology Interdepartmental PhD Program, University of California, Los Angeles, CA.
  • Department of Ophthalmology, University of California, Irvine, CA.
  • Gavin Herbert Eye Institute, University of California, Irvine, CA.

ORCID-Profile: Sathishkumar Chandrakumar, Kaustabh Ghosh

Förderung

  • NEI NIH HHS
  • National Eye Institute

Zitieren

APA

Chandrakumar, S., Santiago Tierno, I., Agarwal, M., Matisioudis, N., Kern, T. S., & Ghosh, K. (2023). Subendothelial Matrix Stiffening by Lysyl Oxidase Enhances RAGE-Mediated Retinal Endothelial Activation in Diabetes. Diabetes. https://doi.org/10.2337/db22-0761

Vancouver

Chandrakumar S, Santiago Tierno I, Agarwal M, Matisioudis N, Kern TS, Ghosh K. Subendothelial Matrix Stiffening by Lysyl Oxidase Enhances RAGE-Mediated Retinal Endothelial Activation in Diabetes. Diabetes. 2023. doi:10.2337/db22-0761

BibTeX
@article{Chandrakumar2023,
  author = {Chandrakumar, Sathishkumar and Santiago Tierno, Irene and Agarwal, Mahesh and Matisioudis, Nikolaos and Kern, Timothy S and Ghosh, Kaustabh},
  title = {Subendothelial Matrix Stiffening by Lysyl Oxidase Enhances RAGE-Mediated Retinal Endothelial Activation in Diabetes},
  journal = {Diabetes},
  year = {2023},
  doi = {10.2337/db22-0761}
}
Kostenlos starten →